BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25330286)

  • 1. Mouse-hamster chimeric prion protein (PrP) devoid of N-terminal residues 23-88 restores susceptibility to 22L prions, but not to RML prions in PrP-knockout mice.
    Uchiyama K; Miyata H; Yano M; Yamaguchi Y; Imamura M; Muramatsu N; Das NR; Chida J; Hara H; Sakaguchi S
    PLoS One; 2014; 9(10):e109737. PubMed ID: 25330286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central residues in prion protein PrP
    Pasiana AD; Miyata H; Chida J; Hara H; Imamura M; Atarashi R; Sakaguchi S
    J Biol Chem; 2022 Sep; 298(9):102381. PubMed ID: 35973512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region.
    Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S
    Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prion protein devoid of the N-terminal residues 25-50 on prion pathogenesis in mice.
    Das NR; Miyata H; Hara H; Uchiyama K; Chida J; Yano M; Watanabe H; Kondoh G; Sakaguchi S
    Arch Virol; 2017 Jul; 162(7):1867-1876. PubMed ID: 28255815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
    Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of transgenic mice expressing chimeric sheep, bovine and human PrP genes to sheep scrapie.
    Gombojav A; Shimauchi I; Horiuchi M; Ishiguro N; Shinagawa M; Kitamoto T; Miyoshi I; Mohri S; Takata M
    J Vet Med Sci; 2003 Mar; 65(3):341-7. PubMed ID: 12679564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.
    Telling GC; Scott M; Mastrianni J; Gabizon R; Torchia M; Cohen FE; DeArmond SJ; Prusiner SB
    Cell; 1995 Oct; 83(1):79-90. PubMed ID: 7553876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain-dependent role of copper in prion disease through binding to histidine residues in the N-terminal domain of prion protein.
    Hara H; Miyata H; Chida J; Sakaguchi S
    J Neurochem; 2023 Nov; 167(3):394-409. PubMed ID: 37777338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
    Weissmann C
    FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of the prion gene complex.
    Mastrangelo P; Westaway D
    Biochem Cell Biol; 2001; 79(5):613-28. PubMed ID: 11716303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and biochemical characterization of mice expressing prion protein devoid of the octapeptide repeat region after infection with prions.
    Yamaguchi Y; Miyata H; Uchiyama K; Ootsuyama A; Inubushi S; Mori T; Muramatsu N; Katamine S; Sakaguchi S
    PLoS One; 2012; 7(8):e43540. PubMed ID: 22927985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.
    Weissmann C; Fischer M; Raeber A; Büeler H; Sailer A; Shmerling D; Rülicke T; Brandner S; Aguzzi A
    Rev Sci Tech; 1998 Apr; 17(1):278-90. PubMed ID: 9638817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion protein transgenes and the neuropathology in prion diseases.
    DeArmond SJ; Prusiner SB
    Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.
    Korth C; Kaneko K; Groth D; Heye N; Telling G; Mastrianni J; Parchi P; Gambetti P; Will R; Ironside J; Heinrich C; Tremblay P; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4784-9. PubMed ID: 12684540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice.
    Carlson GA; Ebeling C; Yang SL; Telling G; Torchia M; Groth D; Westaway D; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5690-4. PubMed ID: 7911243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convection-enhanced delivery of AAV2-PrPshRNA in prion-infected mice.
    Ahn M; Bajsarowicz K; Oehler A; Lemus A; Bankiewicz K; DeArmond SJ
    PLoS One; 2014; 9(5):e98496. PubMed ID: 24866748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion infection of mouse neurospheres.
    Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.